Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

FTSE All-Share News

FTSE All-Share

FTSE All-Share (ASX) Index Information
Index Value: 5,643.44
Change:  -10.74 (-0.19%)
Open: 5,654.32
High: 5,654.32
Low: 5,586.48
Yest. Close: 5,643.43994
FTSE All-Share Live PriceLast checked at -
Deutsche bank starts TP Icap at 'buy'
8 Jun 2026

Deutsche bank starts TP Icap at 'buy'

(Sharecast News) - Deutsche Bank initiated coverage of interdealer broker TP Icap at 'buy' with a 415p price target on Monday as it said it was "more ...

Neo Energy Metals suspends CFO Schutte amid misconduct investigation
8 Jun 2026

Neo Energy Metals suspends CFO Schutte amid misconduct investigation

(Alliance News) - Neo Energy Metals PLC on Monday said it had suspended its Chief Financial Officer De Wet Schutte "while investigating potential misc...

MBDA acquires Centum T&S assets in France
8 Jun 2026

MBDA acquires Centum T&S assets in France

PARIS, June 8 (Reuters) - ​European ⁠missile maker MBDA ​said on Monday it had acquired ​most ‌of the activities of ⁠French electronic engineering fir...

LONDON MARKET OPEN: FTSE 100 falls after fresh Middle East strikes
8 Jun 2026

LONDON MARKET OPEN: FTSE 100 falls after fresh Middle East strikes

(Alliance News) - Stock prices in London opened lower on Monday, as investor confidence was hit by a fresh round of strikes between Israel and Iran.

Market News BP + 6 more shares
Tate & Lyle recommends sweetened takeover bid from US-based Ingredion
8 Jun 2026

Tate & Lyle recommends sweetened takeover bid from US-based Ingredion

(Alliance News) - Tate & Lyle PLC on Monday recommended an acquisition bid from US peer Ingredion Inc at a GBP3.8 billion enterprise value.

Deutsche Bank cuts targets for utility stocks as Labour leadership speculation rises
8 Jun 2026

Deutsche Bank cuts targets for utility stocks as Labour leadership speculation rises

(Sharecast News) - Deutsche Bank has downgraded its rating on National Grid from and lowered target prices for stocks across the UK-listed utilities s...

IN BRIEF: On the Beach starts GBP10 million share buyback
8 Jun 2026

IN BRIEF: On the Beach starts GBP10 million share buyback

On the Beach Group PLC - Manchester, England-based package holiday retailer - Launches GBP10 million share buyback, saying it will add to GBP50 millio...

IN BRIEF: Balfour Beatty says US military housing arm exits monitoring
8 Jun 2026

IN BRIEF: Balfour Beatty says US military housing arm exits monitoring

Balfour Beatty PLC - London-based infrastructure construction - Subsidiary Balfour Beatty Communities LLC on Saturday completes the independent compli...

Tate & Lyle to be acquired by Ingredion in £2.7bn deal
8 Jun 2026

Tate & Lyle to be acquired by Ingredion in £2.7bn deal

(Sharecast News) - Tate & Lyle has agreed to be taken over by US peer Ingredion in a £2.7bn deal, it was confirmed on Monday, sending shares in t...

LONDON BRIEFING: Tate & Lyle agrees GBP2.7 billion Ingredion takeover
8 Jun 2026

LONDON BRIEFING: Tate & Lyle agrees GBP2.7 billion Ingredion takeover

(Alliance News) - Tate & Lyle agrees to a GBP2.7 billion takeover by US rival Ingredion, boohoo and Revolution Beauty agree a new licensing partnershi...

Balfour Beatty says post-scandal monitoring of US unit has ended
8 Jun 2026

Balfour Beatty says post-scandal monitoring of US unit has ended

(Sharecast News) - Balfour Beatty said a long-running compliance monitoring of its US subsidiary Balfour Beatty Communities had ended after a fraud sc...

Ingredion in talks to buy UK's Tate & Lyle for $3.6 billion, Bloomberg News reports
7 Jun 2026

Ingredion in talks to buy UK's Tate & Lyle for $3.6 billion, Bloomberg News reports

June 7 (Reuters) - ​U.S. food ingredients maker Ingredion is in advanced talks to ​acquire ‌Britain's Tate & Lyle in a deal valued at £2.7 billion...

Corporate News Ingredion + 2 more shares
AstraZeneca hails phase 3 trial results of inhibitor Ultomiris
7 Jun 2026

AstraZeneca hails phase 3 trial results of inhibitor Ultomiris

(Alliance News) - AstraZeneca PLC on Saturday announced new data on its kidney disease treatment Ultomiris.

PRESS: BA warns fares may rise further if fuel costs stay high
7 Jun 2026

PRESS: BA warns fares may rise further if fuel costs stay high

(Alliance News) - International Consolidated Airlines Group SA's British Airways may raise ticket prices further if elevated fuel costs persist, as Ch...

Air New Zealand plans for elevated fuel costs into 2027
6 Jun 2026

Air New Zealand plans for elevated fuel costs into 2027

* CEO says further fare hikes possible, ​but demand ⁠could soften

Travel & Leisure Boeing + 2 more shares